sublingual tirzepatide clinical trial - An Overview Sublingual tirzepatide for needle-free weight-loss

This article focuses on the monitoring and management of steroid-induced diabetes and hyperglycaemia (see Box 1 ), with an emphasis on blood-glucose-lowering drugs, including insulin

Each animal was anesthetized with Ketamine hydrochloride plus Xylazine (100 and 2 mg/kg im

Gentiopicroside protects neurons from astrocyte-mediated inflammatory injuries by inhibition of nuclear factor-b and mitogen-activated protein kinase signaling pathways

Excessive FAs in the circulatory system promote insulin secretion from pancreatic beta cells, upregulate the expression of renal uric acid reabsorption proteins Glucose transporter type 9 (GLUT9) and urate transporter 1 (URAT1), and reduce the level of uric acid excretion protein ATP-binding cassette transporter G2 (ABCG2), resulting in elevated serum uric acid levels ( Figure 4 )